請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42655
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賴美淑(Mei-Shu Lai) | |
dc.contributor.author | Hsin-Yang Huang | en |
dc.contributor.author | 黃信揚 | zh_TW |
dc.date.accessioned | 2021-06-15T01:18:54Z | - |
dc.date.available | 2010-09-16 | |
dc.date.copyright | 2009-09-16 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-07-27 | |
dc.identifier.citation | 1. 衛生署. 65歲以上男性糖尿病盛行率達28.5% 衛生署呼籲控制體重 多運動多蔬果 2009年 6月12日 [cited 2009年 7月6日]; Available from: http://www.doh.gov.tw/CHT2006/DM/DM2_p01.
2. International Diabetes Federation. Diabetes Atlas 2006 [cited 2008 November 14]; third edition 3. 翁瑞亨;徐瑞祥;謝玉娟. 臺灣地區糖尿病共同照護現況. 臺灣醫學. 91 ;6(4): 569-73. 4. 台東縣衛生局. 台東縣97年度糖尿病共同照護網推動委員會會議資料. 台東縣衛生局4樓; 2008. 5. Wen CPMDD, Tsai SPP, Chung W-SIM. A 10-Year Experience with Universal Health Insurance in Taiwan: Measuring Changes in Health and Health Disparity. Ann. Intern. Med 2008;148(4):258-67 6. Kahn R, Anderson JE. Improving Diabetes Care: The Model for Health Care Reform. Diabetes Care. 2009;32(6):1115-8. 7. Lin T, Chou P, Lai MS, Tsai ST, Tai TY. Direct costs-of-illness of patients with diabetes mellitus in Taiwan. Diabetes Res. Clin. Pract. 2001;54(S1):43-6. 8. 衛生署國民健康局. 糖尿病防治手冊(糖尿病預防、診斷與控制流程指引). [cited 2008 11月30日 ]; Available from: http://www.bhp.doh.gov.tw/health91/1-3-11-1.pdf 9. De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, et al. Quality of Care and Outcomes in Type 2 Diabetic Patients: A comparison between general practice and diabetes clinics. Diabetes Care. 2004;27(2):398-406. 10. Greenfield S, Rogers W, Mangotich M, Carney MF, Tarlov AR. Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialties. Results from the medical outcomes study. JAMA. 1995;274(18):1436-44. 11. McAlister FA, Majumdar SR, Eurich DT, Johnson JA. The effect of specialist care within the first year on subsequent outcomes in 24 232 adults with new-onset diabetes mellitus: population-based cohort study. Qual Saf Health Care. 2007;16(1):6-11. 12. Schaars CF, Denig P, Kasje WN, Stewart RE, Wolffenbuttel BHR, Haaijer-Ruskamp FM. Physician, Organizational, and Patient Factors Associated With Suboptimal Blood Pressure Management in Type 2 Diabetic Patients in Primary Care. Diabetes Care. 2004;27(1):123-8. 13. 盧介祥. 醫院對於糖尿病病人照護之負責度(accountability)的研究----評估一地區醫院內糖尿病專科門診及一般門診照護之負責度與品質改善: [碩士論文]. 國立臺灣大學; 2002. 14. Tseng FY , Lai MS . Effects of Physician Specialty on Use of Antidiabetes Drugs, Process and Outcomes of Diabetes Care in a Medical Center. J. Formos. Med. Assoc. 2006 ;105(10):821-31. 15. Saydah SH, Fradkin J, Cowie CC. Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes. JAMA. 2004;291(3):335-42. 16. Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412-9. 17. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, et al. Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988-2002. Ann Intern Med. 2006;144(7):465-74. 18. 劉見祥;曲同光;陳玉敏. 糖尿病共同照護與健保給付. 臺灣醫學. 2002;6:4:581-4. 19. Nancy Dean Beaulieu DRH. Putting Smart Money to Work for Quality Improvement. Health Services Research. 2005;40(5p1):1318-34. 20. Yu NC, Su HY, Tsai ST, Lin BJ, Shiu R-S, Hsieh Y-C, et al. ABC control of diabetes: Survey data from National Diabetes Health Promotion Centers in Taiwan. Diabetes Res. Clin. Pract. 2009;84(2):194-200. 21. Tseng FY, Lai MS, Syu CY, Lin CC. Professional accountability for diabetes care in Taiwan. Diabetes Res. Clin. Pract. 2006;71(2):192-201. 22. Mangione CM, Gerzoff RB, Williamson DF, Steers WN, Kerr EA, Brown AF, et al. The Association between Quality of Care and the Intensity of Diabetes Disease Management Programs. Ann Intern Med. 2006 July 18, 2006;145(2):107-16. 23. Grant RW, Buse JB, Meigs JB, for the University HealthSystem Consortium Diabetes Benchmarking Project Team. Quality of Diabetes Care in U.S. Academic Medical Centers: Low rates of medical regimen change. Diabetes Care. 2005;28(2):337-442. 24. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, et al. Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus. Ann Intern Med. 2006;144(7):475-84. 25. Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, Safford MM, et al. Race, Ethnicity, Socioeconomic Position, and Quality of Care for Adults With Diabetes Enrolled in Managed Care: The Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2005;28(12):2864-70. 26. 許惠恒. 糖尿病醫療給付改善方案在某醫學中心實施成效探討: [碩士論文].國立臺灣大學; 2003. 27. 徐慧君;翁慧卿;林育慈. 糖尿病患介入疾病管理在經濟面、臨床面及滿意度成效評估之初探--以南部某區域醫院糖尿病病患為例. 醫務管理期刊. 2004;5 (2):222-42. 28. Tien KJ, Hung HC, Hsiao JY, Hsu SC, Hsin SC, Shin SJ, et al. Effectiveness of comprehensive diabetes care program in Taiwanese with type 2 diabetes. Diabetes Res. Clin. Pract. 2008;79(2):276-83. 29. 李璟佩, 朱正一, 吳篤安, 傅振宗, 李哲全, 王懿萱, et al. Comparison of the Diabetes Regular Care Model and the 'Diabetes Share Care Disease Management' Model in Eastern Taiwan. 慈濟醫學. 2007;19:2:66-732. 30. 郝立智;馬瀰嘉;趙海倫. 某地區教學醫院糖尿病門診病患個案管理照護之成效探討. 中華民國內分泌暨糖尿病學會會刊. 2007 20 (4):11-33. 31. 李待弟. 全民健康保險糖尿病醫療給付改善方案初步影響評估: [碩士論文] 臺灣大學; 2007. 32. 黃三桂, 王悅萍, 錢慶文. 疾病管理對糖尿病患醫療資源耗用之影響. 醫務管理期刊. 2002;3:2:35-48. 33. American diabetes association. Standards of Medical Care in Diabetes Diabetes Care. 2009;32(Supplement_1):S13-61. 34. 郭熟娟;陳重榮;梁深維. 門診糖尿病病患個案管理照護之成效. 北市醫學雜誌. 2005;2 (2):157-66. 35. 林紹雯, 陳明琪, 柯碧玲, 張雅芬, 陳素娥. 糖尿病共同照護網實施成效:中部某區域醫院為例. 健康促進暨衛生教育雜誌. 92.12;23:55-66. 36. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The Quality of Health Care Delivered to Adults in the United States. N Engl J Med.2003;348(26):2635-45 37. Wagner EH, Austin BT, Michael Von K. Organizing Care for Patients with Chronic Illness. The Milbank Quarterly. 1996;74(4):511-44. 38. Bodenheimer T, Wagner EH, Grumbach K. Improving Primary Care for Patients With Chronic Illness. JAMA. 2002;288(14):1775-9. 39. Siminerio LM. Diabetes Educators: Implementing the Chronic Care Model. Diabetes Educ 2008;34(3):451-6. 40. 賴美淑;邱淑媞. 糖尿病共同照護之概念與內涵. 臺灣醫學. 91.07;6:4:560-8. 41. Sowden AJ, Sheldon TA, Alberti G. Shared care in diabetes.BMJ.1995;310(6973):142-3. 42. P. L. Hoskins PMF. Sharing the care of diabetic patients between hospital and general practitioners: Does it work? Diabet. Med..1992;10: 81-6. 43. the Diabetes Integrated Care Evaluation Team Integrated care for diabetes: clinical, psychosocial, and economic evaluation. BMJ. 1994;308(6938):1208-12. 44. Siminerio LM, Piatt G, Zgibor JC. Implementing the chronic care model for improvements in diabetes care and education in a rural primary care practice. Diabetes Educ. 2005 ;31(2):225-34. 45. Piatt GA, Orchard TJ, Emerson S, Simmons D, Songer TJ, Brooks MM, et al. Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention. Diabetes Care. 2006 ;29(4):811-7. 46. Siminerio LM, Piatt GA, Emerson S, Ruppert K, Saul M, Solano F, et al. Deploying the chronic care model to implement and sustain diabetes self-management training programs. Diabetes Educ. 2006 ;32(2):253-60. 47. Kimura J, DaSilva K, Marshall R. Population management, systems-based practice, and planned chronic illness care: integrating disease management competencies into primary care to improve composite diabetes quality measures. Dis Manag. 2008 ;11(1):13-22. 48. Peterson KA, Radosevich DM, O'Connor PJ, Nyman JA, Prineas RJ, Smith SA, et al. Improving Diabetes Care in Practice: Findings from the TRANSLATE trial. Diabetes Care. 2008;31(12):2238-43. 49. Bodenheimer T, Wagner EH, Grumbach K. Improving Primary Care for Patients With Chronic Illness: The Chronic Care Model, Part 2. JAMA. 2002;288(15):1909-14. 50. Griffin S, Kinmonth AL. Diabetes care: the effectiveness of systems for routine surveillance for people with diabetes. Cochrane Database Syst Rev. 2000(2):CD000541. 51. S. Del Prato A-MF, N. Munro, R. Nesto, P. Zimmet, B. Zinman,. Improving glucose management: Ten steps to get more patients with type 2 diabetes to glycaemic goal. Int. J. Clin. Pract.2005;59(11):1345-55. 52. P. Aschner JL, M. McGill,. The team approach to diabetes management: partnering with patients. Int. J. Clin. Pract. 2007;61(s157):22-30. 53. Sadur C, Moline N, Costa M, Michalik D, Mendlowitz D, Roller S, et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care.1999;22(12):2011-7. 54. Senior PA, MacNair L, Jindal K. Delivery of Multifactorial Interventions by Nurse and Dietitian Teams in a Community Setting to Prevent Diabetic Complications: A Quality-Improvement Report. Am. J. Kidney Dis. 2008;51(3):425-34. 55. Choe HMB, Steven J. ; Cooke, David Using a Multidisciplinary Team and Clinical Redesign to Improve Blood Pressure Control in Patients With Diabetes. Qual Manag Health Care. 2008;17 (3):227-33. 56. Ohman-Strickland PA, Orzano AJ, Hudson SV, Solberg LI, DiCiccio-Bloom B, O'Malley D, et al. Quality of diabetes care in family medicine practices: influence of nurse-practitioners and physician's assistants. Ann Fam Med. 2008 ;6(1):14-22. 57. National Diabetes Educational Program. Team Care : Comprehensive Lifetime Management for Diabetes. 2001 [cited 2008 October 25]; Available from: http://ndep.nih.gov/diabetes/pubs/TeamCare.pdf 58. Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of Quality Improvement Strategies for Type 2 Diabetes on Glycemic Control: A Meta-Regression Analysis. JAMA. 2006;296(4):427-40. 59. Sequist TD, Gandhi TK, Karson AS, Fiskio JM, Bugbee D, Sperling M, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc. 2005 ;12(4):431-7. 60. Schmittdiel J, McMenamin SB, Halpin HA, Gillies RR, Bodenheimer T, Shortell SM, et al. The use of patient and physician reminders for preventive services: results from a National Study of Physician Organizations. Prev Med 2004;39(5):1000-6. 61. Meulepas MA, Braspenning JC, de Grauw WJ, Lucas AE, Harms L, Akkermans RP, et al. Logistic support service improves processes and outcomes of diabetes care in general practice. Fam Pract. 2007;24(1):20-5. 62. Burden AC. Improving care for patients with diabetes: the role of simple reminders. Fam Pract. 2007 ;24(1):1-2. 63. 陳鈺如. 志工電話提醒對糖尿病患者血糖控制的成效探討 [碩士論文].台中: 中山醫學大學; 2003. 64. Wagner EH, Grothaus LC, Sandhu N, Galvin MS, McGregor M, Artz K, et al. Chronic Care Clinics for Diabetes in Primary Care: A system-wide randomized trial. Diabetes Care. 2001;24(4):695-700. 65. Tsa AC, Morton SC, Mangione CM, Keeler EB. A Meta-analysis of Interventions to Improve Care for Chronic Illnesses. Am J Manag Care. 2005;11:478-88. 66. world health organization. Adherence to long term therapies. Geneva; 2003. 67. 蔡政麟, 葉玲玲, 楊志良, 孫培然. 納入糖尿病共同照護網後影響病患遵醫囑行為之研究--以某區域教學醫院為例. 童綜合醫學雜誌. 96.12;1:1:11-22. 68. Cramer JA. A Systematic Review of Adherence With Medications for Diabetes. Diabetes Care. 2004;27(5):1218-24. 69. Kindmalm L, Melander A, Nilsson J. Refill adherence of antihyperglycaemic drugs related to glucose control in patients with type 2 diabetes. Acta Diabetol 2007;44(4):209-13 70. Donnelly LA, Morris AD, Evans JMM, for the DARTS/MEMO collaboration. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM. 2007;100(6):345-50. 71. Lau DT, Nau DP. Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals With Type 2 Diabetes. DiabetesCare.2004;27(9):2149-53. 72. Osterberg L, Blaschke T. Adherence to Medication. N Engl J Med. 2005;353(5):487-97. 73. Karve SBMS, Cleves MAP, Helm MMD, Hudson TJP, West DSRP, Martin BCPP. An Empirical Basis for Standardizing Adherence Measures Derived From Administrative Claims Data Among Diabetic Patients. Med Care 2008;46(11):1125-33. 74. 林瑞祥. 糖尿病照護品質監測. 臺灣醫學. 2002;6:4:574-80. 75. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA. The Diabetes Quality Improvement Project: Moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care. 2001;24(10):1815-20. 76. Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of American Diabetes Association Clinical Practice Recommendations Among U.S. Adults With Diabetes, 1999-2002: The National Health and Nutrition Examination Survey. Diabetes Care. 2006;29(3):531-7. 77. 蔡世澤. 台灣糖尿病照護現況與省思. 臨床醫學. 2000;45:316-20. 78. Tai TY T, ChuangLM , Tsai ST, The Diabcare Study G. Treatment of Type 2 Diabetes Mellitus in a Primary Care Setting in Taiwan: Comparison with Secondary/Tertiary Care. J. Formos. Med. Assoc 2006 ;105(2):105-17. 79. McClain MR, Wennberg DE, Sherwin RW, Steinmann WC, Rice JC. Trends in the Diabetes Quality Improvement Project Measures in Maine From 1994 to 1999. Diabetes Care. 2003;26(3):597-601. 80. Weiner ML, Judith Cross-Sectional versus Longitudinal Performance Assessments in the Management of Diabetes. Med Care. 2004;42(2 (Suppl):): 34-9. 81. Voorham JD, Petra ; Wolffenbuttel, Bruce H. R. ; Haaijer-Ruskamp, Flora Cross-Sectional Versus Sequential Quality Indicators of Risk Factor Management in Patients with Type 2 Diabetes. Med. Care. 2008;46:133-41. 82. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12. 83. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med. 2008;358(24):2545-59. 84. Pogach L, Engelgau M, Aron D. Measuring Progress Toward Achieving Hemoglobin A1c Goals in Diabetes Care: Pass/Fail or Partial Credit. JAMA. 2007;297(5):520-3. 85. Selby JV, Uratsu CS, Fireman B, Schmittdiel JA, Peng T, Rodondi N, et al. Treatment Intensification and Risk Factor Control: Toward More Clinically Relevant Quality Measures. Med Care. 2009;47:395-402. 86. Aron D, Rajan M, Pogach LM. Summary measures of quality of diabetes care: comparison of continuous weighted performance measurement and dichotomous thresholds. Int J Qual Health Care. 2007;19(1):29-36. 87. Bessie Ann Young EL, Michael Von Korff,Greg Simon,. Diabetes Complications Severity Index and Risk of Mortality,Hospitalization, and Healthcare Utilization. Am J Manag Care. 2008;14:15-24. 88. Andersson K, Melander A, Svensson C, Lind O, Nilsson JLG. Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. Eur J Public Health. 2005;15(6):621-6. 89. Chuang LM, Tsai ST, Huang BY, Tai TY. The current state of diabetes management in Taiwan. Diabetes Res. Clin. Pract. 2001;54(S 1):55-65. 90. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999;22(3):403-8. 91. Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). BMJ. 1998;316(7134):823-8. 92. Chen C-C, Li C-I. Factors Related to Poor Glycemic Control in Type 2 Diabetic Outpatients in a Medical Center. Mid Taiwan J Med. 2005;10:90-8. 93. 莊嬌榮, 林宏達, 鄭綺. 影響第2型糖尿病患血糖控制因素的探討. Endocrinol Diabetol. 1999;12(3):39-50. 94. HOPE Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. The Lancet. 2000;355(9200):253-9. 95. American Diabetes Association. Standards of Medical Care in Diabetes--2008. Diabetes Care. 2008 January 1, 2008;31(S 1):S12-54. 96. Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA. Reduced Mortality Associated With the Use of ACE Inhibitors in Patients With Type 2 Diabetes. Diabetes Care. 2004;27(6):1330-4. 97. The ONTARGET Investigators. Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. N Engl J Med. 2008;358(15):1547-59. 98. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, et al. Preserving Renal Function in Adults With Hypertension and Diabetes: A Consensus Approach. Am J Kidney Dis. 2000;36:646-61. 99. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338 :b1665-. 100. David M. Nathan JBB, Mayer B. Davidson E F Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. Diabetes Care 2008;31:1-11 101. Massi-Benedetti M, Orsini-Federici M. Treatment of Type 2 Diabetes With Combined Therapy: What are the pros and cons? Diabetes Care. 2008;31(S2):S131-5. 102. Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, et al. Effect of intensive insulin therapy on [beta]-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. The Lancet.371(9626):1753-60. 103. Wright A, Burden ACF, Paisey RB, Cull CA, Holman RR. Sulfonylurea Inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care. 2002;25(2):330-6. 104. Young LH, Wackers FJT, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes: The DIAD Study: A Randomized Controlled Trial.JAMA.2009;301(15):1547-55. 105. Piette JD, Kerr EA. The Impact of Comorbid Chronic Conditions on Diabetes Care. Diabetes Care. 2006;29(3):725-31. 106. Nichols GA, Hillier TA, Javor K, Brown JB. Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care. 2000;23(3):273-7. 107. Gerlof D. Valk, Didi M.W. Kriegsman, Willem J.J. Assendelft. Patient education for preventing diabetic foot ulceration: A systematic review Endocrinol Meta Clin North Am. 2002;31:633-58. 108. B Hurwitz CG, and J Yudkin. Prompting the clinical care of non-insulin dependent (type II) diabetic patients in an inner city area: one model of community care. BMJ 1993;306:624-30. 109. Ackermann RT, Thompson TJ, Selby JV, Safford MM, Stevens M, Brown AF, et al. Is the Number of Documented Diabetes Process-of-Care Indicators Associated With Cardiometabolic Risk Factor Levels, Patient Satisfaction, or Self-Rated Quality of Diabetes Care? Diabetes Care. 2006;29(9):2108-13. 110. So WY, Tong PCY, Ko GTC. Effects of Protocol-Driven Care Versus Usual Outpatient Clinic Care on Survival Rates in Patients with Type 2 Diabetes. Am J Manag Care. 2003;9:606-15. 111. Ford ES, Li C, Little RR, Mokdad AH. Trends in A1C Concentrations Among U.S. Adults With Diagnosed Diabetes From 1999 to 2004. Diabetes Care. 2008;31(1):102-4. 112. 王志堅;陳美筵;侯紀君. 是否加入糖尿病共同照護網個人認知與健康行為之探討. 秀傳醫學雜誌. 2006;6:93-100. 113. Solberg LI, Asche SE, Pawlson LG, Scholle SH, Shih SC. Practice systems are associated with high-quality care for diabetes. Am J Manag Care 2008;14(2):85-92. 114. Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, et al. The Efficacy of Intensive Dietary Therapy Alone or Combined with Lovastatin in Outpatients with Hypercholesterolemia. N Engl J Med. 1993;328(17):1213-9. 115. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308(6925):367-72. 116. Kong APS, Yang X, Ko GTC, So W-Y, Chan W-B, Ma RCW, et al. Effects of Treatment Targets on Subsequent Cardiovascular Events in Chinese Patients With Type 2 Diabetes. Diabetes Care. 2007;30(4):953-9. 117. 中華民國糖尿病學會. 2006第2型糖尿病照護指引. 第2版 臺北市; 2006. 118. Adams AS, Trinacty CM, Zhang F, Kleinman K, Grant RW, Meigs JB, et al. Medication Adherence and Racial Differences in A1C Control. Diabetes Care. 2008;31(5):916-21. 119. Peterson KA, Radosevich DM, O'Connor PJ, Nyman JA, Prineas RJ, Smith SA, et al. Improving Diabetes Care in Practice. Diabetes Care. 2008;31(12):2238-43. 120. Norris SL, Engelgau MM, Venkat Narayan KM. Effectiveness of Self-Management Training in Type 2 Diabetes. Diabetes Care. 2001;24(3):561-87. 121. 陳秀菊. 降血糖藥物種類、劑量調整與糖尿病患血糖控制之關係 [碩士論文].東海大學; 2005. 122. 黃憶玫. 糖尿病照護成效的探討:以台東某區域醫院糖尿病共同照護網為例 [碩士論文]:慈濟大學 2008. 123. Chin MH, Drum, Melinda L, Guillen, Myriam , Rimington, Ann , Levie, Jessica R, Kirchhoff, Anne C, Quinn, Michael T. Improving and Sustaining Diabetes Care in Community Health Centers With the Health Disparities Collaboratives. Med. Care. 2007;45:1135-43. 124. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet. N Engl J Med. 2001;344(1):3-10. 125. Varma S, Boyle LL, Varma MR, Piatt GA. Controlling the ABCs of diabetes in clinical practice: A community-based endocrinology practice experience. Diabetes Res. Clin. Pract. 2008;80(1):89-95. 126. Malik S, Lopez V, Chen R, Wu W, Wong ND. Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Diabetes Res. Clin. Pract. 2007;77(1):126-33. 127. Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Jr, Clark LT, Hunninghake DB, et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110(2):227-39. 128. McEwen LN, Bilik D, Johnson SL, Halter JB, Karter AJ, Mangione CM, et al. Predictors and Impact of Intensification of Antihyperglycemic Therapy in Type 2 Diabetes. Diabetes Care. 2009;32(6):971-6. 129. Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, et al. Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes. N Engl J Med. 2007;357(17):1716-30. 130. Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care. 1998;21(2):261-4. 131. Kilpatrick ES. HbA1c measurement. J Clin Pathol. 2004;57(4):344-5. 132. Reynolds TM, Smellie WSA, Twomey PJ. Glycated haemoglobin (HbA1c) monitoring. BMJ. 2006;333(7568):586-8. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42655 | - |
dc.description.abstract | 背景:
糖尿病是國人十大死因之一,有賴不同專業醫療團隊的照護、衞教與定期併發症篩檢。過去研究發現結構式照護會提升糖尿病照護過程與成效,國內少有研究是以地區醫院家庭醫學科的糖尿病結構式照護為標的,且成效皆以橫斷性指標評估,過去也沒有研究用連續性指標評估糖尿病結構式照護。 目的: 利用健保局「糖尿病醫療給付改善方案」在台東某地區醫院實施期間,由家庭醫學專科醫師負責下,遵從糖尿病學會治療指引,以橫斷性指標與連續性指標比較有無接受結構式照護模式的第2型糖尿病患照護過程、成效與病患遵醫囑行為。 方法: 研究期間是民國96年10月1日至97年12月31日,以回溯性世代追蹤方式,以家庭醫學科固定就診的第2型糖尿病患為研究對象,根據病人是否有填寫同意書加入結構式照護,分成結構式照護組與一般照護組。結構式照護過程上配合不同醫療專業團隊介入,導入臨床資訊系統與醫療服務流程重新設計等措施。 結果: 在家庭醫學科固定就醫的第2型糖尿病患,結構式照護組有120位病人,一般照護組有99位。在性別、族別、年齡、教育程度、糖尿病罹病年數與醫師的藥物處方分布並不因病人有無接受結構式照護而差別,但接受結構式照護模式的病人會有較多次慢性病處方的釋出。 結構式照護模式介入顯著提升散瞳眼底檢查比例達90%、足部檢查比例達99.2%、HbA1C檢查≧2次的比例達100% ,曾接種肺炎鏈球菌疫苗的比例達43.3%,相較於一般照護組有較好的照護過程盡責度。 未調整其他變項下,結構式照護模式介入的橫斷性指標:HbA1C<7%的比例是32.5%,LDL<100 mg/dl的比例是53.3%,SBP<130 mmHg的比例是50%,只有LDL<100 mg/dl的比例結構式照護組優於接受一般醫療照護組(P=0.002);連續性指標方面:血糖控制良好或改善的比例是60%,顯著優於接受一般醫療照護的病人(P=0.01),收縮壓控制良好或改善的比例連續性指標是80.0%,總膽固醇控制良好或改善的比例是80.8%,上述兩項指標與一般照護組比較無統計上差異。 調整其他共變項,糖尿病照護成效的橫斷性指標LDL<100 mg/dl的比例,結構式照護組相較於一般照護組的勝算比是2.58 (95%CI 1.43-4.65);在SBP<130 mmHg與HbA1C<7%的勝算比則兩組無統計上差異;在血糖控制良好或改善的連續性指標結構式照護組相較於一般照護組的勝算比是 3.35 (95%CI 1.61-6.94);在總膽固醇與收縮壓的連續性指標勝算比兩組 無統計上差異。 結構式照護組的平均MPR是0.91±0.14,一般照護組MPR是0.83 ±0.18 (P=0.001);較佳遵醫囑性(MPR≧0.8)兩組的比例分別是83.3%與65.7%,兩組在統計上達顯著差異(P=0.003)。調整其他變項,較佳遵醫囑性的比例結構式照護組相較於一般照護組的勝算比是2.27(95%CI 1.15-4.46)。 結論: 結構式照護介入會有較好的糖尿病照護盡責度。介入的效果主要在血糖的控制,特別是讓個人血糖持續維持在理想範圍內或是有血糖下降進步的成效,以糖化血色素<7%的橫斷性指標是無法呈現其成效,用連續性指標測量才可顯現結構式照護的價值;其次是低密度膽固醇<100 mg/dl的病人比例較高,但收縮壓的照護成效不論是用何種指標測量皆不明顯,而且接受結構式照護模式的病人糖尿病用藥的遵醫囑行為較佳。 | zh_TW |
dc.description.abstract | Background:
Diabetes mellitus (DM) is one of the top ten causes of death in Taiwan. The medical care for DM patients is getting more and more depending on the cooperation of multidisciplinary teams, frequent health educations, and regular follow-up for complications. Few studies have been focused on the effectiveness of DM intervention programs executed by family physicians. In addition, studies in the literature evaluated the effectiveness of DM intervention programs using cross-sectional indicators. None of them evaluated the effectiveness of DM intervention programs using sequential indicators. Objectives: Cross-sectional indicators and sequential indicators were used to evaluate the effectiveness of structured care (SC) for type 2 DM patients in a community hospital in Taitung by family physicians as compared to those who received usual care (UC). Methods: This is a retrospective cohort study. Patients were recruited between October 1, 2007 and January 31, 2008. After patients’ consents were provided, the patients who were regularly followed up for three months or longer in the outpatient clinics of family medicine before recruitment were assigned to the SC group. Others were assigned to the UC group. All patients were followed up for one year after they were assigned to the SC group or the UC group. Bivariate analysis was performed to explore the association between an independent variable and the dependent variable using Chi-square test (or Fisher’s exact test) for dichotomous independent variables or Student’s t test for continuous independent variables. Multivariate logistic regression analysis was also performed to explore the associations between the independent variables of interest and the dependent variables. Results: One hundred and twenty patients were assigned to the SC group and 99 patients were assigned to the UC group. The accountability (process indicator of diabetic care) in SC group is significantly better compared with UC group: more patients (99.2%) in the SC group had annual foot exam than UC group(24.2%)(p-value <0.001); more patients (90%) in the SC group had annual dilated eye exam than UC group(55.6%)(p-value <0.001); more patients (43.3%) in the SC group ever received pneumococcal vaccination than UC group(21.2%)(p-value=0.001);more patients (100%) in the SC group had biannual check up of HbA1C than UC group(96%)(p-value=0.04) . Three cross-sectional indicators were used to compare the two groups before controlling for other confounding variables: more patients (53.3%) in the SC group reach the goal of LDL < 100mg/dL than the UC group (32.3%). (p-value = 0.002); more patients (32.5%) in the SC group reach the goal of HbA1C < 7% than the UC group (21.2%), though the difference is of borderline significance (p-value = 0.062); sixty (50%) participants in the SC group and 40 (40.4%) participants in the UC group reach the goal of SBP < 130 mmHg (p-value = 0.156). As demonstrated by sequential indicators defined as improved or being controlled: 72 (60%) participants in the SC group showed good sequential indicator of HbA1C, while only 42 (42.4%) in the UC group showed good sequential indicator of HbA1C (p-value = 0.010); no significant differences were found between the SC and UC group using sequential indicator of serum total cholesterol (p-value = 1.000) and SBP (p-value = 0.363). After controlling for other confounding variables using multivariate logistic regression analysis, the participants in the SC group were more likely to reach the goal of LDL < 100mg/dL than the participants in the UC group (O.R. = 2.58, 95% C.I. = 1.43 – 4.65, p-value = 0.002); no significant differences were shown between the two groups as indicated by cross-sectional indicator of SBP (O.R. = 1.61, 95% C.I. = 0.91 – 2.83, p-value = 0.101) and HbA1C (O.R. = 1.57, 95% C.I. = 0.75 – 3.29, p-value = 0.235). Sequential indicator of HbA1C, serum total cholesterol (T-CHO), and SBP were used to evaluate the effectiveness of structured care after controlling for other confounding variables: significantly more participants in the SC group resulted in good sequential indicator of HbA1C than those in the UC group (O.R. = 3.35, 95% C.I. = 1.61 – 6.94, p-value = 0.001); no significant differences between the SC group and the UC group were found using the sequential indicator of T-CHO (O.R. = 1.41, 95% C.I. = 0.72 – 2.74, p-value = 0.318) and sequential indicator of SBP (O.R. = 0.93, 95% C.I. = 0.47 – 1.84, p-value = 0.839). Higher proportion of participants(83.3%)in the SC group had better adherence, defined as medication possession rate (MPR) greater than 0.8, than those in the UC group(65.7%) (p-value = 0.003). SC group was significantly associated with good MPR as compared to the UC group after controlling for other confounding variables (O.R. = 2.27, 95% C.I. = 1.15 – 4.46, p-value = 0.017). Conclusion: The structured care significantly has better accountability of process of diabetic care and improves the intermediate outcome of type 2 DM patients as indicated by sequential indicator of HbA1C, though the effect did not appear if cross-sectional indicator of HbA1C is used to evaluate the effectiveness of the program. Furthermore, MPR demonstrate that the structured care is significantly associated with better adherence. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T01:18:54Z (GMT). No. of bitstreams: 1 ntu-98-R96846001-1.pdf: 525720 bytes, checksum: 0aa4b32f5b8d6aee872b41c73e54a1d3 (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 第一章 前言 4
第二章 文獻回顧 6 第一節 美國糖尿病照護現況 6 第二節 台灣糖尿病照護策略與研究 6 第三節 慢性疾病之照護模式 12 壹 慢性病照護模式 12 貳 共同照護照護模式 15 第四節 糖尿病之照護模式研究 16 第五節 不同介入方式對糖尿病照護影響 19 壹 多專業的共同照護 19 貳 電腦提示系統促進糖尿病照護改善 20 參 醫療服務流程重新設計 22 第六節 遵醫囑行為(ADHERENCE)與血糖控制 23 第七節 糖尿病照護成效橫斷性與連續性指標之研究 24 第三章 研究目的 28 第四章 研究材料及方法 29 第一節 研究設計與對象 29 第二節 研究方式與資料蒐集 31 壹 結構式照護組之實施方式 31 貳 資料收集 32 參 研究變項與定義 32 第三節 研究假說與統計方法 35 第五章 結果 38 第一節 人口變項、藥物使用、收縮壓與生化值分析 38 第二節 併發症、身體質量指數與照護過程的專業盡責度 39 壹 糖尿病併發症、後測身高、體重與身體質量指數分布 39 貳 糖尿病照護過程的專業盡責度 39 第三節 糖尿病照護成效 40 壹 經介入後,橫斷性指標分析結果 40 貳 經介入後,連續性指標之分析 40 第四節 糖尿病用藥遵醫囑行為之分析 41 第五節 複邏輯回歸調整共變項,糖尿病照護成效結果分析 41 壹 橫斷性指標之結果 41 貳 連續性指標之結果 42 參 糖尿病用藥遵醫囑行為 42 第六章 結論與討論 51 第一節 結論 51 第二節 討論 52 第三節 研究之特點與限制 64 第七章 建議 65 參考文獻 67 圖表目錄 圖 1慢性病照護模式 14 圖 2 研究架構圖 30 圖 3 研究期間與資料蒐集日期 31 圖 4 組內前後測糖化血色素比較 60 表 1國內糖尿病衛教臨床成效相關臨床研究 10 表 2兩組人口變項與藥物使用之分布 44 表 3兩組前測血壓之分布 44 表 4兩組前測生化值之分布 45 表 5研究期間糖尿病併發症之分布 45 表 6民國98年1月至3月兩組身高與體重之分布 46 表 7研究期間糖尿病照護過程盡責度指標分析 46 表 8後測生化值橫斷性指標相關性分析 47 表 9照護成效連續性指標相關性分析 47 表10用藥遵醫囑行為指標相關性分析 47 表 11 調整共變項,結構式照護組糖化血色素<7%的勝算比 48 表 12調整共變項,結構式照護組SBP<130MMHG的勝算比 48 表 13調整共變項,結構式照護組LDL <100MG/DL的勝算比 48 表 14調整共變項,結構式照護組血糖控制良好或獲得改善的勝算比 49 表 15調整共變項,結構式照護組收縮壓控制良好或獲得改善的勝算比 49 表 16調整共變項,結構式照護組總膽固醇控制良好或獲得改善的勝算比 49 表 17調整共變項,結構式照護組較佳糖尿病用藥遵醫囑行為的勝算比 50 | |
dc.language.iso | zh-TW | |
dc.title | 地區醫院家庭醫學科之糖尿病照護成效橫斷性結果指標與連續性結果指標之比較研究 | zh_TW |
dc.title | The comparison of cross-sectional indicators with sequential indicators to evaluate the intermediate outcomes of type 2 diabetic patients cared for by the family physician in a community hospital | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 季瑋珠,葉彥伯,曾芬郁,李永凌 | |
dc.subject.keyword | 糖尿病,連續性指標,橫斷性指標,結構式照護,遵醫囑行為,盡責度, | zh_TW |
dc.subject.keyword | diabetes mellitus,sequential indicator,cross-sectional indicator,structured car,adherence,accountability, | en |
dc.relation.page | 75 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-07-27 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 513.4 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。